CytoDyn (CYDY) Free Cash Flow (2010 - 2026)
CytoDyn (CYDY) posted Free Cash Flow of -$5.5 million for Q1 2026, down 26.87% on a QoQ basis from -$4.4 million in Q4 2025, and down 11.36% year-over-year from -$6.2 million in Q1 2025.
CytoDyn (CYDY) Free Cash Flow (2010 - 2026) Analysis & Trends
CytoDyn's Free Cash Flow history runs 17 years deep, the most recent figure standing at -$5.5 million for Q1 2026.
- Quarterly Free Cash Flow fell 11.36% year-over-year to -$5.5 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was -$18.0 million (down 278.41% YoY) and the FY2025 annual result came in at -$8.8 million, up 20.19% from the prior year.
- Free Cash Flow was -$5.5 million for Q1 2026 at CytoDyn, down from -$4.4 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $5.4 million in Q3 2024 and bottomed at -$11.1 million in Q3 2022.
- A 5-year average of -$4.4 million and a median of -$4.4 million in 2022 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2024 — Free Cash Flow jumped 221.02% — and 2025, when it plunged 243.21%.
- CytoDyn's Free Cash Flow stood at -$4.4 million in 2022, then soared by 43.21% to -$2.5 million in 2023, then tumbled by 43.33% to -$3.6 million in 2024, then declined by 21.31% to -$4.4 million in 2025, then decreased by 26.87% to -$5.5 million in 2026.
- Business Quant data shows CYDY's Free Cash Flow at -$5.5 million in Q1 2026, -$4.4 million in Q4 2025, and -$2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | CytoDyn | 267.79 Mn | 267.79 Mn | - | -5.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -5.52 Mn |
| Feb 28, 2026 | -5.52 Mn |
| Nov 30, 2025 | -4.35 Mn |
| Nov 30, 2025 | -4.35 Mn |
| Aug 31, 2025 | -2.45 Mn |
| Aug 31, 2025 | -2.45 Mn |
| May 31, 2025 | -5.66 Mn |
| May 31, 2025 | -5.66 Mn |
| Feb 28, 2025 | -4.96 Mn |
| Feb 28, 2025 | -4.96 Mn |
| Nov 30, 2024 | -3.59 Mn |
| Nov 30, 2024 | -3.59 Mn |
| Aug 31, 2024 | 5.44 Mn |
| Aug 31, 2024 | 5.44 Mn |
| May 31, 2024 | -1.65 Mn |
| May 31, 2024 | -1.65 Mn |
| Feb 29, 2024 | -2.34 Mn |
| Feb 29, 2024 | -2.34 Mn |
| Nov 30, 2023 | -2.50 Mn |
| Nov 30, 2023 | -2.50 Mn |